Asset Intelligence / Hyperliquid Context
MRNA
Market guides and dated reports for MRNA. Browse recent coverage below or use the archive pages to find older articles.
MRNA references 1 share of Moderna, Inc. common stock (Nasdaq: MRNA), quoted in USD. Moderna develops messenger RNA (mRNA) medicines, including infectious-disease vaccines and oncology therapeutics.
Live Structure
Market Status
Loading current market structure…
- Builderxyz
- Categorystock
- Tracked Marketxyz:MRNA
- Latest TweetOpen
No other live markets from this builder in the current screener.
No same-category alternatives are live in the current screener snapshot.
Archive Summary
Latest Archived Thesis
Wolfe's $9.2 Billion Intismeran Call Snaps Moderna's Post-Readout Unwind
Moderna closed August 25 at $158.83, up 14.36 percent, after Wolfe Research finally took the stock off Underperform and put $9.2 billion of unadjusted peak sales on intismeran autogene. That is the sell side capitulating four sessions late, not new clinical data. The actual catalyst was August 19, when the Phase 3 INTerpath-001 readout added roughly $44 billion of market value in a day and cost short sellers about $5.5 billion; everything since has been an argument over how much of it to give back. On Hyperliquid, the MRNA perp gained 15.26 percent over 22 hours, and its base print sat below the Nasdaq session low because the perp never stopped trading.
Archive
MRNA Article Archive
Wolfe's $9.2 Billion Intismeran Call Snaps Moderna's Post-Readout Unwind
Moderna closed August 25 at $158.83, up 14.36 percent, after Wolfe Research finally took the stock off Underperform and put $9.2 billion of unadjusted peak sales on intismeran autogene. That is the sell side capitulating four sessions la…
How to Trade MRNA (Moderna) on Hyperliquid
Moderna is the Nasdaq-listed biotech behind the mRNA platform that produced a COVID vaccine, a newly approved seasonal flu shot, and, as of August 19, 2026, the first personalized mRNA cancer therapy to win a Phase 3 trial. The stock clo…
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.
HIP-3 Explained: Builder-Deployed Perps on Hyperliquid
HIP-3 lets anyone deploy a perpetual futures market on Hyperliquid — no approval, no gatekeepers. Builder mechanics, fees, and live markets.
Funding Rates Explained: A Trader's Guide (2026)
Funding rates decide if you pay or earn holding a perp position. How Hyperliquid's hourly funding works, reading rate signals, and cash-and-carry arbitrage.